In the mouse-TNBS colitis model, oral administration of Imm124E increased serum levels of the anti-inflammatory cytokine IL-10 and promoted both CD4+CD25+ and CD4+Foxp3+ Tregs. This evidence concerns the gene IL10 and colitis.